CE program to be offered to all UPMC Pharmacists and Pharmacy Technicians across the system. This CE program will explore innovative strategies to optimize antimicrobial therapy and support earlier hospital discharge for patients with complex infections. Participants will review common antimicrobial-related barriers to discharge, examine the role of stewardship and transitions-of-care interventions through the POSITIVE Program, evaluate emerging evidence for long-acting antimicrobial therapies such as dalbavancin and rezafungin, and discuss how oral therapies, shorter treatment durations, and long-acting agents can be incorporated into patient-centered discharge planning.

This activity will enhance pharmacists' ability to collaborate with infectious diseases providers, hospitalists, case managers, nurses, and transitions-of-care teams to identify antimicrobial-related barriers to discharge and recommend evidence-based treatment alternatives. Improved pharmacist involvement in discharge planning can support more efficient transitions of care, reduce avoidable hospital length of stay, and promote safe, patient-centered management of complex infections.